by Sage Publications
Welcome to the official free Podcast site from SAGE for Public Health. SAGE is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets with principal offices in Los Angeles, London, New Delhi, and Singapore.
Language
🇺🇲
Publishing Since
6/3/2010
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
August 25, 2025
<p class="MsoNormal"><span style="mso-no-proof: yes;">Listen to the sponsored podcast featuring Cassandra Gardner, PhD, Associate Director of Medical Affairs at BD-Canada, and Marcy Saxe-Braithwaite, DBA, Associate Vice President of Executive Search Services at The Medfall Group, as they discuss the clinical efficacy of vacuum-assisted biopsies and vacuum-assisted excision technologies in the diagnosis and treatment pathway of breast cancer and how they can help streamline patient care and conserve healthcare resources.</span></p> <p class="MsoNormal"><span style="mso-no-proof: yes;">Key messages include how health leaders can maximize diagnostic efficiency by ensuring accurate and timely detection while minimizing unnecessary procedures. Vacuum-assisted technologies require less anaesthesia, fewer supplies, shorter hospital stays, and fewer post-operative visits, making them a viable and sustainable alternative to surgery and improving health outcomes for patients. </span></p> <p class="MsoNormal"><span style="mso-no-proof: yes;">View the article <a href= "https://journals.sagepub.com/doi/10.1177/08404704251348812">here</a>.</span></p>
April 22, 2025
<div class="x_elementToProof" data-olk-copy-source="MessageBody"> Listen to the podcast by Tracee Pratt, Executive Director, Women’s Health Programs at Lois Hole Hospital and Sturgeon Community Hospital in Alberta and the Women’s Health Lead for the Edmonton Zone speak about the evolution and success of the robotic-assisted surgery (RAS) program in the OR, and the downstream benefits. Tracee will share insights into how they operationalized the RAS program to successfully achieve a zero-wait time for targeted gynecologic-oncology procedures.</div> <div class="x_elementToProof"> </div> <div class="x_elementToProof">This session is moderated by Tara Klassen, PhD, the Provincial Program Lead – Surgical Innovation and Scientist for the Evidence Decision Support Program. Tara is engaging key stakeholders in the long-term planning for RAS, while considering the evidence, health economics, and organizational impact to make evidence-informed decisions about the equitable access and expanded use of RAS in the province. This novel approach to adoption of innovation will transform the delivery of surgical care with the objective of providing timely access to high-quality surgical care, regardless of where patients reside in the province.</div> <div class="x_elementToProof"> </div> <div class="x_elementToProof">View the article <a href= "https://journals.sagepub.com/doi/full/10.1177/08404704251327561">here</a>.</div>
September 25, 2024
<p class="MsoNormal">Listen to the podcast with Don Juzwishin, PhD, FCCHL, and Dan Breznitz, PhD, as they provide more detail on CIFAR’s program on Innovation, Equity and the Future of Prosperity, and talk with author Jane Gingrich, PhD, about her work in the United Kingdom related to innovation strategies and how they shape citizens’ public health behaviours. In an era of rising nationalism, public authorities face the temptation to lean into national sentiment to encourage citizens to engage with public health policies - from taking vaccines to promoting healthy lifestyles. Her research suggests that public health authorities should be cautious with nationalist framing, as it may be ineffective or counterproductive.<span style= "mso-spacerun: yes;"> </span> Jane Gingrich, PhD, is a Professor of comparative social policy at the University of Oxford in the Department of Social Policy and Intervention.</p> <p class="MsoNormal">View the article <a href= "https://journals.sagepub.com/doi/full/10.1177/08404704241271159">here</a>.</p>
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
Welcome to the official free Podcast site from SAGE for Public Health.
SAGE is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets with principal offices in Los Angeles, London, New Delhi, and Singapore.
This podcast updates weekly.
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Information about guest appearances is not available.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.